'EuroVacc 02' HIV Vaccine Trial Begins
By Bill Freeman Lausanne, Switzerland and London, United Kingdom, February 16, 2005 — The European Vaccine Effort against HIV/AIDS today announced that a phase I clinical trial of novel investigational vaccines comprising DNA-HIV-C and NYVAC-HIV-C for the prevention of HIV infection has started in Lausanne and London in February 2005. Lausanne, Switzerland and London, United …